SELECTIVE VENOUS SAMPLING CATHETERIZATION FOR LOCALIZATION OF PERSISTING MEDULLARY-THYROID CARCINOMA

被引:54
作者
ABDELMOUMENE, N
SCHLUMBERGER, M
GARDET, P
ROCHE, A
TRAVAGLI, JP
FRANCESE, C
PARMENTIER, C
机构
[1] INST GUSTAVE ROUSSY,DEPT NUCL MED,F-94805 VILLEJUIF,FRANCE
[2] INST GUSTAVE ROUSSY,DEPT INTERVENT RADIOL,F-94805 VILLEJUIF,FRANCE
[3] INST GUSTAVE ROUSSY,DEPT GEN SURG,F-94805 VILLEJUIF,FRANCE
关键词
D O I
10.1038/bjc.1994.224
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Selective venous sampling catheterisation was performed in 19 patients with medullary thyroid carcinoma without known distant metastases for persistent hypercalcitoninaemia after surgery. Calcitonin (CT) gradients were found in the neck and/or the mediastinum in 18 patients and in five patients at distant sites also. After Venous catheterisation, 13 patients were subjected to repeat surgery. Neck and/or mediastinal tumour foci were found in 12 patients at the sites of the CT gradients. Of these, nine patients had only cervicamediastinal CT gradients: after reoperation, the serum CT level normalised in one, significantly decreased in five, and did not change in three, and no neck relapse occurred after a mean follow-up of 5.3 years. Distant metastases emerged clinically in all five patients with distant gradients and in only one of the 14 patients with no distant gradient. In conclusion, selective venous catheterisation is the most sensitive tool for the localisation of residual disease and for the early detection of distant metastases. However, in patients with only local disease, biochemical cure is rarely obtained after reoperation.
引用
收藏
页码:1141 / 1144
页数:4
相关论文
共 12 条
  • [1] BENMRAD MD, 1989, CANCER, V63, P133, DOI 10.1002/1097-0142(19890101)63:1<133::AID-CNCR2820630121>3.0.CO
  • [2] 2-3
  • [3] CALMETTES C, 1979, NOUV PRESSE MED, V8, P3847
  • [4] LOCALIZATION OF OCCULT PERSISTING MEDULLARY-THYROID CARCINOMA BEFORE MICROSURGICAL REOPERATION - HIGH-SENSITIVITY OF SELECTIVE VENOUS CATHETERIZATION
    FRANKRAUE, K
    RAUE, F
    BUHR, HJ
    BALDAUF, G
    LORENZ, D
    ZIEGLER, R
    [J]. THYROID, 1992, 2 (02) : 113 - 117
  • [5] GAUTVIK KM, 1989, CANCER, V63, P175, DOI 10.1002/1097-0142(19890101)63:1<175::AID-CNCR2820630128>3.0.CO
  • [6] 2-9
  • [7] CHANGING CONCEPTS IN THE MANAGEMENT OF HEREDITARY AND SPORADIC MEDULLARY-THYROID CARCINOMA
    GRAUER, A
    RAUE, F
    GAGEL, RF
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1990, 19 (03) : 613 - 635
  • [8] CONSTRUCTION AND CLINICAL VALIDATION OF A SENSITIVE AND SPECIFIC ASSAY FOR SERUM MATURE CALCITONIN USING MONOCLONAL ANTI-PEPTIDE ANTIBODIES
    MOTTE, P
    VAUZELLE, P
    GARDET, P
    GHILLANI, P
    CAILLOU, B
    PARMENTIER, C
    BOHUON, C
    BELLET, D
    [J]. CLINICA CHIMICA ACTA, 1988, 174 (01) : 35 - 54
  • [9] PARMENTIER C, 1985, THYROID CANCER, P103
  • [10] TISELL LE, 1986, SURGERY, V99, P60